Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Exchange Rate Effect (2020 - 2022)

Historic Exchange Rate Effect for Xeris Biopharma Holdings (XERS) over the last 3 years, with Q3 2022 value amounting to $1000.0.

  • Xeris Biopharma Holdings' Exchange Rate Effect rose 15000.0% to $1000.0 in Q3 2022 from the same period last year, while for Jun 2023 it was $1000.0, marking a year-over-year increase of 12000.0%. This contributed to the annual value of -$3000.0 for FY2021, which is 8636.36% up from last year.
  • Per Xeris Biopharma Holdings' latest filing, its Exchange Rate Effect stood at $1000.0 for Q3 2022, which was up 15000.0% from -$1000.0 recorded in Q1 2022.
  • Xeris Biopharma Holdings' 5-year Exchange Rate Effect high stood at $6000.0 for Q4 2020, and its period low was -$2000.0 during Q3 2021.
  • Over the past 3 years, Xeris Biopharma Holdings' median Exchange Rate Effect value was $0.0 (recorded in 2021), while the average stood at $500.0.
  • As far as peak fluctuations go, Xeris Biopharma Holdings' Exchange Rate Effect tumbled by 13333.33% in 2021, and later soared by 15000.0% in 2022.
  • Over the past 3 years, Xeris Biopharma Holdings' Exchange Rate Effect (Quarter) stood at $6000.0 in 2020, then crashed by 133.33% to -$2000.0 in 2021, then skyrocketed by 150.0% to $1000.0 in 2022.
  • Its last three reported values are $1000.0 in Q3 2022, -$1000.0 for Q1 2022, and -$2000.0 during Q4 2021.